Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major

Heart

Volumn 95, Issue 20, 2009, Pages 1688-1693

  Pepe, A ^a   Positano, V ^a   Capra, M ^b   Maggio, A ^c   Pinto, C L ^d   Spasiano, A ^e   Forni, G ^f   Derchi, G ^f   Favilli, B ^a   Rossi, G ^g   Cracolici, E ^h   Midiri, M ^h   Lombardi, M ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b G Di Cristina Children's Hospital   (Italy)

^c VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^d Villa Sofia Hospital   (Italy)

^e CARDARELLI HOSPITAL   (Italy)

^f GALLIERA HOSPITAL   (Italy)

^g INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^h UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CINEANGIOCARDIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART VENTRICLE FUNCTION; HUMAN; IMAGE ANALYSIS; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THALASSEMIA MAJOR;

ADULT; BETA-THALASSEMIA; CICATRIX; FEMALE; HUMANS; IRON OVERLOAD; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIUM; NECROSIS; RETROSPECTIVE STUDIES;

EID: 70349628638     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.156497     Document Type: Article

References (30)

1. Weatherall DJ, Clegg JB. Thalassemia - a global public health problem. Nat Med 1996;2:847-849 (Pubitemid 26296746)
2. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-1193 (Pubitemid 39390442)
3. Engle MA, Erlandson M, Smith CH. Late cardiac complication of chronic, severe, refractory anemia with hemochromatosis. Circulation 1964;30:698-705.
4. MacDonald RA, Mallory GK. Hemochromatosis and hemosiderosis: study of 211 autopsied cases. Arch Intern Med 1960;105:686-700.
5. Buja LM, Roberts WC. Iron in the heart: etilogy and clincal significance. Am J Med 1971;51:209-212
6. Tanner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006;8:543-547
7. Kremastinos DTh, Tiniakos G, Theodorakis GN, et al. Myocarditis in beta-thalassemia major. Circulation 1995;91:66-71.
8. Grisaru D, Rachmilewitz EA, Mosseri M, et al. Cardiopulmonary assessment in beta talassemia major. Chest 1990;98:1138-1142 (Pubitemid 20381277)
9. Sanyal SK, Johnson W, Jayalakshmamma B, et al. Fatal "iron heart" in an adolescent: biochemical and ultrastructural aspect of the heart. Pediatrics 1975;55:336-341
10. Olson LJ, Edwards WD, McCall JT, et al. Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 1987;10:1239-1243
11. Olson LJ, Edwards WD. Endomyocardial biopsy in hemochromatosis: clinicolpathologic correlates in six cases. J Am Coll Cardiol 1989;13:116-120
12. Cogliandro T, Derchi G, Mancuso L, et al. Guideline recommendations for heart complications in thalassemia major. J Cardiovasc Med 2008;9:515-525
13. Mavrogeni S, Gotsis ED, Berdousi E, et al. Myocardial and hepatic T2* magnetic resonance evaluation in ex-thalassemic patients after bone-marrow transplantation. Int J Cardiovasc Imaging 2007;23:739-745 (Pubitemid 350055697)
14. Wood JC, Tyszka JM, Carson S, et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004;103:1934-1936 (Pubitemid 38268994)
15. Anderson LJ, Holden S, Davies B, et al. Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179
16. Pepe A, Lombardi M, Positano V, et al. Evaluation of the efficacy of oral deferiprone in b-thalassemia major by multi-slice multi-echo T2*. Eur J Haematol 2006;76:183-192
17. Pepe A, Positano V, Santarelli MF, et al. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 2006;23:662-668
18. Positano V, Pepe A, Santarelli MF, et al. Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR Biomed 2007;20:578-590 (Pubitemid 47496898)
19. Maceira AM, Prasad SK, Khan M, et al. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Magn Reson Imaging 2006;8:417-426
20. Wu E, Judd RM, Vargas JD, et al. Visualisation of the presence, location and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-28 (Pubitemid 32056497)
21. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59
22. Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of nonischaemic cardiomyopathies. Eur Heart J 2005;26:1461-1474 (Pubitemid 41373486)
23. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847 (Pubitemid 28213628)
24. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. Circulation 2002;105:539-542 (Pubitemid 34262671)
25. Positano V, Pingitore A, Giorgetti A, et al. A fast and effective method to assess myocardial necrosis by means of contrast magnetic resonance imaging. J Cardiovasc Magn Reson 2005;7:487-494 (Pubitemid 40563340)
26. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-193 (Pubitemid 40139730)
27. St Pierre TG. Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility. Lancet 2003;361:182.
28. Kremastinos DT, Flevari P, Spyropoulou M, et al. Association of heart failure in homozygous beta-thalassemia with the major histocompatibility complex. Circulation 1999;100:2074-2078 (Pubitemid 29532058)
29. Matsumori A, Shimada T, Chapman NM, et al. Myocarditis and heart failure associated with hepatitis C virus infection. J Card Fail 2006;12:293-298
30. Westwood MA, Shah F, Anderson LJ, et al. Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy. J Magn Reson Imaging 2007;26:564-568 (Pubitemid 350194577)